{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:44:56Z","timestamp":1781196296364,"version":"3.54.1"},"reference-count":42,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Pain is one reason some rheumatology patients may consider use of medical cannabis, a product increasingly perceived as a safe and neglected natural treatment option for many conditions. Legalization of recreational cannabis in Canada will promote access to cannabis. Physicians must therefore provide patients with the best evidence-based information regarding the medicinal effects and harm of cannabis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>The Canadian Rheumatology Association (CRA) mandated the development of a position statement for medical cannabis and the rheumatology patient. The current literature regarding the effects of medical cannabis for rheumatology patients was assessed, and a pragmatic position statement to facilitate patient care was developed by the Therapeutics Committee of the CRA and approved by the CRA board.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>There are no clinical trials of medical cannabis in rheumatology patients. Evidence is insufficient about the benefit of pharmaceutical cannabinoids in fibromyalgia, osteoarthritis, rheumatoid arthritis, and back pain, but there is evidence of a high risk of harm. Extrapolating from other conditions, medical cannabis may provide some symptom relief for some patients. Short-term risks of psychomotor effects can be anticipated, but longterm risks have not been determined and are of concern.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Despite lack of evidence for use of medical cannabis in rheumatology patients, we acknowledge the need to provide empathetic and pragmatic guidance for patient care. This position statement aims to facilitate the dialogue between patients and healthcare professionals in a mutually respectful manner to ensure harm reduction for patients and society.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.181120","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T12:29:17Z","timestamp":1547555357000},"page":"532-538","source":"Crossref","is-referenced-by-count":47,"title":["Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases"],"prefix":"10.3899","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-3175","authenticated-orcid":false,"given":"Mary-Ann","family":"Fitzcharles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Zahedi","family":"Niaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-3741","authenticated-orcid":false,"given":"Glen","family":"Hazlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Canadian Rheumatology Association","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"2019050109251912000_46.5.532.1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"2019050109251912000_46.5.532.2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41584-018-0025-5","article-title":"Cannabinoids for the treatment of rheumatic diseases - where do we stand?","volume":"14","author":"Katz-Talmor","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2019050109251912000_46.5.532.3","unstructured":"Government of Canada . Health_Canada. Cannabis for medical purposes (FY 2017\u201318) - licensed producers: monthly data. [Internet. Accessed November 29, 2018.] Available from: www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-use-marijuana\/licensed-producers\/market-data.html"},{"key":"2019050109251912000_46.5.532.4","first-page":"27","article-title":"Survey results on medical marijuana","volume":"27","year":"2017","journal-title":"CRAJ"},{"key":"2019050109251912000_46.5.532.5","unstructured":"Canadian Rheumatology Association . CRA guideline handbook. [Internet. Accessed November 29, 2018.] Available from: rheum.ca\/wp-content\/uploads\/2017\/11\/CRA_guideline_handbook_revised_final_17-July-2017.pdf"},{"key":"2019050109251912000_46.5.532.6","first-page":"111","article-title":"Simplified guideline for prescribing medical cannabinoids in primary care","volume":"64","author":"Allan","year":"2018","journal-title":"Can Fam Physician"},{"key":"2019050109251912000_46.5.532.7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ejp.1297","article-title":"European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management","volume":"22","author":"Hauser","year":"2018","journal-title":"Eur J Pain"},{"key":"2019050109251912000_46.5.532.8","first-page":"e78","article-title":"Systematic review of systematic reviews for medical cannabinoids: pain, nausea and vomiting, spasticity, and harms","volume":"64","author":"Allan","year":"2018","journal-title":"Can Fam Physician"},{"key":"2019050109251912000_46.5.532.9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ejp.1118","article-title":"Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - an overview of systematic reviews","volume":"22","author":"Hauser","year":"2018","journal-title":"Eur J Pain"},{"key":"2019050109251912000_46.5.532.10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","article-title":"Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials","volume":"30","author":"Fitzcharles","year":"2016","journal-title":"Schmerz"},{"key":"2019050109251912000_46.5.532.11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22727","article-title":"Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials","volume":"68","author":"Fitzcharles","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2019050109251912000_46.5.532.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0183-9"},{"key":"2019050109251912000_46.5.532.13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10067-016-3239-4","article-title":"Opioid use in patients with rheumatoid arthritis 2005\u20132014: a population-based comparative study","volume":"35","author":"Zamora-Legoff","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2019050109251912000_46.5.532.14","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/j.pain.0000000000000706","article-title":"Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis","volume":"157","author":"Ste-Marie","year":"2016","journal-title":"Pain"},{"key":"2019050109251912000_46.5.532.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.004"},{"key":"2019050109251912000_46.5.532.16","unstructured":"Health Canada . Information for health care professionals: cannabis (marihuana, marijuana) and the cannabinoids. [Internet. Accessed December 20, 2018.] Available from: www.hc-sc.gc.ca\/dhpmps\/alt_formats\/pdf\/marihuana\/med\/infoprof-eng.pdf"},{"key":"2019050109251912000_46.5.532.17","first-page":"1083","article-title":"Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations","volume":"60","author":"Kahan","year":"2014","journal-title":"Can Fam Physician"},{"key":"2019050109251912000_46.5.532.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.07.014"},{"key":"2019050109251912000_46.5.532.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2003.00401.x"},{"key":"2019050109251912000_46.5.532.20","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.115"},{"key":"2019050109251912000_46.5.532.21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29036"},{"key":"2019050109251912000_46.5.532.22","unstructured":"Mensinga TT de Vries I Kruidenier M Hunault CC van den Hengel-Koot IS Fijen JW [A double-blind, randomized, placebo controlled, cross-over study on the pharmacokinetics and effects of cannabis.] [Article in Dutch] Nationaal Vergiftigingen Informatie Centrum. RIVM report 267002002\/2006. [Internet. Accessed November 29, 2018.] Available from: www.rivm.nl\/bibliotheek\/rapporten\/267002002.pdf"},{"key":"2019050109251912000_46.5.532.23","unstructured":"Beirness DJ Beasley EE Boase P . A comparison of drug use by fatally injured drivers and drivers at risk. In: Proceedings of the 20th International Conference on Alcohol, Drugs and Traffic Safety (T2013). [Internet. Accessed November 29, 2018.] Available from: www.icadtsinternational.com\/files\/documents\/2013_014.pdf"},{"key":"2019050109251912000_46.5.532.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e536"},{"key":"2019050109251912000_46.5.532.25","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.28"},{"key":"2019050109251912000_46.5.532.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.09.009"},{"key":"2019050109251912000_46.5.532.27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/pch\/pxx017","article-title":"Cannabis and Canada\u2019s children and youth","volume":"22","author":"Grant","year":"2017","journal-title":"Paediatr Child Health"},{"issue":"Suppl 1","key":"2019050109251912000_46.5.532.28","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.mce.2008.02.011","article-title":"Endocannabinoid functions controlling neuronal specification during brain development","volume":"1\u20132","author":"Harkany","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"2019050109251912000_46.5.532.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1206820109"},{"key":"2019050109251912000_46.5.532.30","doi-asserted-by":"publisher","DOI":"10.2174\/1874473710801020114"},{"key":"2019050109251912000_46.5.532.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2010.01441.x"},{"key":"2019050109251912000_46.5.532.32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2019050109251912000_46.5.532.33","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(76)90236-7"},{"key":"2019050109251912000_46.5.532.34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/bfm.2017.0020","article-title":"Marijuana and breastfeeding: applicability of the current literature to clinical practice","volume":"12","author":"Mourh","year":"2017","journal-title":"Breastfeed Med"},{"key":"2019050109251912000_46.5.532.35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00005-015-0352-z","article-title":"Cannabis allergy: what do we know anno 2015","volume":"63","author":"Decuyper","year":"2015","journal-title":"Arch Immunol Ther Exp"},{"key":"2019050109251912000_46.5.532.36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/all.13043","article-title":"Cannabis sativa allergy: looking through the fog","volume":"72","author":"Decuyper","year":"2017","journal-title":"Allergy"},{"key":"2019050109251912000_46.5.532.37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejim.2018.01.019","article-title":"Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2019050109251912000_46.5.532.38","unstructured":"National Academies of Sciences, Engineering, and Medicine . The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017."},{"key":"2019050109251912000_46.5.532.39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.9740\/mhc.2018.03.086","article-title":"A review of medical marijuana for the treatment of posttraumatic stress disorder: real symptom re-leaf or just high hopes?","volume":"8","author":"Shishko","year":"2018","journal-title":"Ment Health Clin"},{"key":"2019050109251912000_46.5.532.40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chest.2018.05.005","article-title":"Marijuana and lung disease","volume":"154","author":"Tashkin","year":"2018","journal-title":"Chest"},{"key":"2019050109251912000_46.5.532.41","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000103"},{"key":"2019050109251912000_46.5.532.42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40119-017-0102-x","article-title":"Cardiovascular complications of marijuana and related substances: A review","volume":"7","author":"Singh","year":"2018","journal-title":"Cardiol Ther"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T13:09:45Z","timestamp":1556716185000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,1]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.3899\/jrheum.181120"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181120","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]}}}